| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
7.1380 | 7.1380 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-9,110.6710 | -5,251.3260 | -834.8950 | -391.9490 | -27.4030 |
|
Operating Income/Expenses
|
-9,110.6710 | -5,251.3260 | -834.8950 | -391.9490 | -27.4030 |
|
Total Operating Profit/Loss
|
-9,103.5330 | -5,244.1880 | -834.8950 | -391.9490 | -27.4030 |
| Total Net Finance Income/Expense
|
-4,268.5370 | -3,981.6050 | -168.8730 | -109.3460 | 0 |
| Net Investment Income
|
2,173.8250 | 803.6800 | -397.5530 | 0 | -- |
| Irregular Income/Expenses
|
252.2620 | 400.8780 | 18,731.5140 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
0 | 0 | -13,226.9260 | 0 | -- |
|
Non-Operating Income/Expenses, Total
|
-1,992.4500 | -2,777.0470 | 4,938.1620 | -109.3460 | 0 |
|
Pretax Income
|
-11,095.9830 | -8,021.2350 | 4,103.2670 | -501.2950 | -27.4030 |
|
Provision for Income Tax
|
0 | 0 | -0.2000 | 0 | -- |
|
Net Income from Continuing Operations
|
-11,095.9830 | -8,021.2350 | 4,103.0670 | -501.2950 | -27.4030 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,095.9830 | -8,021.2350 | 4,103.0670 | -501.2950 | -27.4030 |
|
Net Income after Non-Controlling/Minority Interests
|
-11,095.9830 | -8,021.2350 | 4,103.0670 | -501.2950 | -27.4030 |
|
Net Income Available to Common Stockholders
|
-11,095.9830 | -8,021.2350 | 4,103.0670 | -501.2950 | -27.4030 |
|
Diluted Net Income Available to Common Stockholders
|
-11,095.9830 | -8,021.2350 | 4,103.0670 | -501.2950 | -27.4030 |
| Basic EPS
|
-6.12 | -11.60 | 29.20 | -1.52 | -- |
| Diluted EPS
|
-6.12 | -11.60 | 5.20 | -1.52 | -- |
|
Basic Weighted Average Shares Outstanding
|
1,354.2230 | 682.6520 | 141.0250 | 330.3070 | -- |
|
Diluted Weighted Average Shares Outstanding
|
1,354.2230 | 682.6520 | 804.3940 | 330.3070 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-6,827.4460 | -4,039.6300 | 4,272.1400 | -391.9490 | -27.4030 |
|
EBITDA
|
-6,827.4460 | -4,039.6300 | 4,272.1400 | -391.9490 | -27.4030 |
|
Normalized EBITDA
|
-9,364.1650 | -5,244.1880 | -14,061.8210 | -391.9490 | -27.4030 |
|
Normalized Income
|
-13,632.7020 | -9,225.7930 | -14,229.9956 | -501.2950 | -27.4030 |
|
Total Unusual Items
|
-2,536.7190 | -1,204.5580 | -18,333.9610 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
-2,536.7190 | -1,204.5580 | -18,333.9610 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 0 | -0.8984 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 10/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade